CE
Cerus Corporation
CERS · NASDAQ
$2.65 +0.19% (+$0.01)
1M -1.49%
Market Cap $534.0M
P/E Ratio -
Div. Yield -
ROE 10.31%
Bulios Fair Price
$2.12
20.0% downside
Trenutna cena
$2.65
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CERS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
16 /100
Expensive EV/EBITDA 203.87x
P/S 2.41x
P/B 7.63x
Growth
50 /100
Stable Rev. growth 8.35%
Book val. growth 1.70%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 52.05%
Net margin 3.06%
Op. margin 0.73%
Quality
14 /100
Poor ROIC 1.12%
ROE 10.31%
ROA 3.31%
Debt
28 /100
High Debt/Equity 1.10x
Current ratio 1.83x
Int. coverage 0.16x
Stability
58 /100
Moderate Beta 1.80x
Rev. volatility 10.59%
EPS volatility 17.76%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CERS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Vivek K. Jayaraman
Employees
268
Headquarters
Concord
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report